Home / Publications / Experience & Statistics / Ischemic heart disease

Ischemic heart disease

The statistics of ischemic heart disease: the data of international registers, in which the center from Ukraine took part, confirm that acute coronary syndrome (ACS) without ST-segment elevation is observed more often than with elevated ST-segment. The annual number of cases of ACS is approximately 3 cases per 1000 population. Read more.

Standardization of medical care

  • The Order of the MoH of Ukraine #455 of 02.07.2014 “On approving and implementation of medical and technical documents on standardization of medical care in acute coronary syndrome with ST-segment elevation”. Read more
  • The Order of MoH of Ukraine #164 of 03.03.2016 “On approving and implementation of medical and technical documents on standardization of medical care in acute coronary syndrome without ST-segment elevation”. Read more

Clinical trials including adults /in adults, adults & children/

  • Globally, there are 638 (Phase I – 29, Phase IV – 161) recruiting clinical trials for ischemic heart disease registered at ClinicalTrials.gov.
  • World leaders: the USA – 133, Canada – 55, the Republic of Korea – 54 recruiting trials.
  • CEE leaders: Poland/the Russian Federation – 20, Austria/Hungary – 13, Serbia – 11 recruiting trials.
  • Ukraine: Not yet recruiting – 0; Recruiting – 3; Active, not recruiting – 5 clinical trials.
    • The country experience includes 31 Phase II, II, IV clinical trials totally.
    • 3 recruiting clinical trials are conducted on 36 clinical sites in 18 cities. The city leaders by the number of clinical sites: Kyiv – 8, Kharkiv – 4 sites.
    • 5 active, not recruiting clinical trials are conducted on 47 clinical sites in 19 cities. The city leaders by the number of clinical sites: Kyiv – 11, Kharkiv – 5, Zaporizhia – 4 sites.

Clinical trials on medical devices

  • Globally, there are 194 (Phase I – 6) recruiting clinical trials.
  • World leaders: China – 32, the USA – 31, Germany – 21 recruiting trials.
  • CEE leaders: Hungary/Poland – 5, Latvia/the Russian Federation – 4, Austria/Lithuania – 3 recruiting clinical trial

Clinical trials with stem cells

  • Globally, there are 41 (Phase I – 10) recruiting clinical trials.
  • World leaders: France/the United Kingdom – 8, the USA – 7, Denmark – 5 recruiting trials.
  • CEE leaders: Poland – 2, the Russian Federation – 1 recruiting clinical trial.

Clinical trials for ischemic heart disease including adults in CEE, July 2017

Clinical trials for ischemic heart disease including adults in Ukraine, July 2017

Clinical sites in trials for ischemic heart disease including adults in Ukraine, July 2017


Clinical trials including children /pediatric, in children & adults/

  • Globally, there are 27 (Phase I – 0, Phase IV – 6) recruiting clinical trials for ischemic heart disease registered at ClinicalTrials.gov.
  • World leaders: the USA – 7, Canada – 4, France – 3 recruiting trials.
  • CEE leaders: no recruiting trials.
  • Ukraine:
    • Not yet recruiting – 0; Recruiting – 0; Active, not recruiting – 0 clinical trials.
    • No country international experience.

Clinical trials on medical devices

  • Globally, there are 6 (Phase I – 0) recruiting clinical trials.
  • World leaders: the Republic of Korea – 2, others – 1 recruiting trials.

Clinical trials with stem cells

  • Globally, only 1 recruiting clinical trial: it is conducted in the Islamic Republic of Iran (Phase II).

Non-interventional studies including adults /in adults, adults & children/

  • Globally, there are 342 (on medical devices – 82) recruiting observational studies for ischemic heart disease registered at ClinicalTrials.gov.
  • World leaders: the USA – 69, China – 43, Germany – 38 recruiting studies.
  • CEE leaders: Austria/Poland – 7, the Russian Federation – 5, Hungary – 4 recruiting studies.
  • Ukraine: 1 recruiting observational study: only Kyiv – 4 clinical sites.

Non-interventional studies including children /pediatric, in children & adults/

  • Globally, there are 38 (on medical devices – 5) recruiting observational studies for ischemic heart disease registered at ClinicalTrials.gov.
  • World leaders: the USA – 9, China – 8, Canada/Germany/Italy/the Republic of Korea – 3 recruiting studies.
  • CEE leaders: Austria/the Russian Federation – 1 recruiting study.

NB! The cities located on the non-controlled territories of Ukraine are not included in the statistics.

Publications of

Sergii Gromov

Leave a Reply